Infectologia

Cuidado a idosos durante a pandemia de COVID-19.

15 Mar, 2022 | 13:18h

Caring for older adults during the COVID-19 pandemic – Clinical Microbiology and Infection

---

Coorte retrospectiva | Asma em crianças e adolescentes não está associada a risco aumentado de infecção por SARS-CoV-2.

15 Mar, 2022 | 13:17h

Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents – Pediatrics

Comentário: Kids with asthma not at higher risk of COVID-19, study finds – CIDRAP

Conteúdos relacionados:

We expected people with asthma to fare worse during COVID. Turns out they’ve had a break.

M-A: Asthma does not increase the risk of infection, hospitalization, ICU admission, and mortality from COVID-19

Systematic review: No evidence that patients with asthma are at increased risk of COVID-19 diagnosis, hospitalization or death

Asthma in COVID-19 hospitalizations: An overestimated risk factor?

---

2 anos depois, a evolução do coronavírus ainda surpreende os especialistas, e estes são os motivos.

15 Mar, 2022 | 13:15h

Two years later, coronavirus evolution still surprises experts. Here’s why. – National Geographic

---

“Suprimimos nossa imaginação científica”: 4 especialistas examinam os grandes sucessos e fracassos da resposta à COVID até agora.

15 Mar, 2022 | 13:13h

‘We suppressed our scientific imagination’: four experts examine the big successes and failures of the COVID response so far – The Conversation

---

Estudo randomizado de centro único | Cuidado da hepatite C acessível a usuários de drogas injetáveis.

15 Mar, 2022 | 13:07h

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial – JAMA Internal Medicine (gratuito por tempo limitado)

 

Comentário no Twitter

This randomized clinical trial found that the accessible care model provides a framework for developing treatment programs geared toward engaging, treating, and curing hepatitis C virus infection in people who inject drugs. https://t.co/zauS1gtPgO

— JAMA Internal Medicine (@JAMAInternalMed) March 14, 2022

 

---

M-A | Desfechos similares de betalactâmico em monoterapia vs. terapia combinada para infecções de corrente sanguínea ou pneumonia por Pseudomonas aeruginosa.

15 Mar, 2022 | 13:02h

Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to Pseudomonas aeruginosa: a meta-analysis – International Journal of Antimicrobial Agents (link para o resumo – $ para o texto completo)

---

Revisão sistemática | Efetividade do rastreamento de contatos no controle de doenças infecciosas.

14 Mar, 2022 | 14:06h

Effectiveness of contact tracing in the control of infectious diseases: a systematic review – The Lancet Public Health

---

Revisão sistemática e metarregressão | Duração da efetividade das vacinas contra infecção por SARS-CoV-2 e COVID-19.

14 Mar, 2022 | 14:05h

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression – The Lancet

Comentários:

Review of pre-Omicron data finds COVID-19 vaccine protection from severe disease remains strong at six months – Johns Hopkins University Bloomberg School of Public Health

Waning of COVID-19 vaccine effectiveness: individual and public health risk – The Lancet

Conteúdos relacionados: [Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although it did decrease some (on average, 8-10 percentage points) between one and six months after full vaccination”.

---

Como parar as pandemias antes que elas comecem: lições aprendidas com o SARS-CoV-2.

14 Mar, 2022 | 14:03h

Stopping pandemics before they start: Lessons learned from SARS-CoV-2 – Science

---

A epidemiologia em modificação do SARS-CoV-2.

14 Mar, 2022 | 14:02h

The changing epidemiology of SARS-CoV-2 – Science

---